Original news and analysis on international IP policy
The World Health Organization secretariat record of a International Medical Products Anti-Counterfeiting Taskforce (IMPACT) meeting that took place 26 March are now available online. Intellectual Property Watch reported on the meeting earlier, including statements made by stakeholders (IPW, WHO, 31…
World Health Organization Director General Margaret Chan today opened an expert review process on the way WHO handled the outbreak of a pandemic influenza virus last year. In her opening speech, Chan called it the “most closely watched and carefully…
The United Kingdom Parliament late last night approved a controversial digital economy bill that allows the court to impose obligations on internet service providers to limit internet access of its users deemed to have infringed online copyrights.
In the aftermath of the recent protracted fights over healthcare, the United States has seen a wave of intellectual property-related policy activity
The UN Convention on Biological Diversity last month hailed Cali, Colombia as the birthplace of a protocol they hope will lead to an international regime on access and benefit-sharing by their October 2010 deadline. But, while it is clear the late March negotiation in Cali brought significant progress, participants reported difficult disagreements and in the final days, signs that there is yet more work to be done.
世界卫生组织就处理假冒伪劣（conterfeit）药品问题继续开展工作，但是上周晚些时候召开的一个会议暴露出一些方面对该组织的工作方式表示担心。
Alors que l’Organisation mondiale de la Santé (OMS) continue de travailler sur la question des médicaments contrefaits, une réunion organisée en fin de semaine dernière a révélé des inquiétudes quant à la manière dont ce travail est mené.
La Organización Mundial de la Salud (OMS) continúa trabajando en el tema de los medicamentos falsificados, pero la semana pasada una reunión reveló preocupaciones progresivas sobre la forma de conducir la labor.
Applause burst from the plenary chamber this week as delegates at last found, in a semicolon, the solution to a long-running and at times sharply divided multilateral negotiation.
Work to address counterfeit medicines continues at the World Health Organization, but a meeting late last week revealed ongoing concerns about the way it is being conducted.
The World Health Organization’s handling of the recent pandemic influenza outbreak will be examined by an independent panel of experts beginning in April. Meanwhile, new reports from the WHO are available on influenza and on intellectual property and innovation.
Two officials have been appointed to the Office of the United States Trade Representative: Michael Punke as deputy USTR and permanent representative to the World Trade Organization in Geneva, and Isi Siddiqui as the new chief agricultural negotiator.